Semaglutide Main Chain (9-37)
A peptide starting material in the synthesis of semaglutide
Catalog Number | 40788 |
Alternative Name(s) | Semaglutide Intermediate 29|Semapeptide |
Research Area | Antioxidant Activity|Cardiovascular Diseases|Cardiovascular System|Diabetes|Endocrinology & Metabolism|Hormones & Receptors|Ischemia|Lipid Peroxidation|Metabolic Diseases|Neurodegenerative Disorders|Neuroprotection|Neuroscience|Oxidative Stress & Reactive Species|Parkinson’s Disease|Stroke |
Molecular Formula | C142H216N38O45 |
CAS# | 1169630-82-3 |
Purity | ≥98% |
Inchi | InChI=1S/C142H216N38O45/c1-16-72(10)113(138(223)159-75(13)118(203)166-97(58-81-60-152-85-34-24-23-33-83(81)85)128(213)168-93(54-69(4)5)129(214)177-111(70(6)7)136(221)165-87(37-28-52-151-142(148)149)121(206)154-61-103(188)160-86(36-27-51-150-141(146)147)120(205)156-64-110(199)200)179-130(215)95(55-78-29-19-17-20-30-78)169-125(210)91(45-49-108(195)196)164-124(209)88(35-25-26-50-143)162-117(202)74(12)157-116(201)73(11)158-123(208)90(43-46-102(145)187)161-104(189)62-155-122(207)89(44-48-107(193)194)163-126(211)92(53-68(2)3)167-127(212)94(57-80-38-40-82(186)41-39-80)170-133(218)99(65-181)173-135(220)101(67-183)174-137(222)112(71(8)9)178-132(217)98(59-109(197)198)171-134(219)100(66-182)175-140(225)115(77(15)185)180-131(216)96(56-79-31-21-18-22-32-79)172-139(224)114(76(14)184)176-105(190)63-153-119(204)84(144)42-47-106(191)192/h17-24,29-34,38-41,60,68-77,84,86-101,111-115,152,181-186H,16,25-28,35-37,42-59,61-67,143-144H2,1-15H3,(H2,145,187)(H,153,204)(H,154,206)(H,155,207)(H,156,205)(H,157,201)(H,158,208)(H,159,223)(H,160,188)(H,161,189)(H,162,202)(H,163,211)(H,164,209)(H,165,221)(H,166,203)(H,167,212)(H,168,213)(H,169,210)(H,170,218)(H,171,219)(H,172,224)(H,173,220)(H,174,222)(H,175,225)(H,176,190)(H,177,214)(H,178,217)(H,179,215)(H,180,216)(H,191,192)(H,193,194)(H,195,196)(H,197,198)(H,199,200)(H4,146,147,150)(H4,148,149,151)/t72-,73-,74-,75-,76+,77+,84-,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,111-,112-,113-,114-,115-/m0/s1 |
Inchi Key | WCICZXNLSJRZSX-LEHZXNOYSA-N |
SMILES | O=C(O)CC[C@H](N[H])C(NCC(N[C@]([C@H](O[H])C)([H])C(N[C@H](C(N[C@]([C@H](O[H])C)([H])C(N[C@@H](CO[H])C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CO[H])C(N[C@@H](CO[H])C(N[C@@H](CC1=CC=C(O[H])C=C1)C(N[C@H](C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H](CCC(N[H])=O)C(N[C@H](C(N[C@H](C(N[C@@H](CCCCN[H])C(N[C@@H](CCC(O)=O)C(N[C@H](C(N[C@@](C(N[C@H](C(N[C@@H](CC2=CN([H])C3=C2C=CC=C3)C(N[C@H](C(N[C@@H](C(C)C)C(N[C@@H](CCC/N=C(N[H])/N)C(NCC(N[C@@H](CCC/N=C(N[H])/N)C(NCC(O)=O)=O)=O)=O)=O)=O)CC(C)C)=O)=O)C)=O)([H])[C@@H](C)CC)=O)CC4=CC=CC=C4)=O)=O)=O)C)=O)C)=O)=O)=O)=O)CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O)CC5=CC=CC=C5)=O)=O)=O |
Size | 5 mg |
Supplier Page | https://www.caymanchem.com/product/40788 |